21 – 30 of 152
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The structure of songbird MHC class I reveals antigen binding that is flexible at the N-terminus and static at the C-terminus
(
- Contribution to journal › Article
-
Mark
Editorial : Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Enhanced protein synthesis is a defining requirement for neonatal B cell development
2023) In Frontiers in Immunology(
- Contribution to journal › Article
-
Mark
Synovial monocytes contribute to chronic inflammation in childhood-onset arthritis via IL-6/STAT signalling and cell-cell interactions
(
- Contribution to journal › Article
-
Mark
Antibodies against Porphyromonas gingivalis in serum and saliva and their association with rheumatoid arthritis and periodontitis. Data from two rheumatoid arthritis cohorts in Sweden
(
- Contribution to journal › Article
-
Mark
Insertion of an immunodominant T helper cell epitope within the Group A Streptococcus M protein promotes an IFN-γ-dependent shift from a non-protective to a protective immune response
(
- Contribution to journal › Article
-
Mark
Substrate-specific binding of 8-oxoguanine DNA glycosylase 1 (OGG1) reprograms mucosal adaptations to chronic airway injury
(
- Contribution to journal › Scientific review
-
Mark
Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
(
- Contribution to journal › Article
-
Mark
Identifying biomarkers deciphering sepsis from trauma-induced sterile inflammation and trauma-induced sepsis
(
- Contribution to journal › Article
-
Mark
Resistance to anti-PD-1/anti-PD-L1 : galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
(
- Contribution to journal › Article